Logo image of CHEK

CHECK CAP LTD (CHEK) Stock Fundamental Analysis

USA - NASDAQ:CHEK - IL0011336851 - Common Stock

1.62 USD
+0.08 (+5.19%)
Last: 10/24/2025, 8:15:05 PM
1.59 USD
-0.03 (-1.85%)
After Hours: 10/24/2025, 8:15:05 PM
Fundamental Rating

0

Overall CHEK gets a fundamental rating of 0 out of 10. We evaluated CHEK against 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of CHEK have multiple concerns. CHEK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CHEK had negative earnings in the past year.
In the past year CHEK has reported a negative cash flow from operations.
In the past 5 years CHEK always reported negative net income.
In the past 5 years CHEK always reported negative operating cash flow.
CHEK Yearly Net Income VS EBIT VS OCF VS FCFCHEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

The Return On Assets of CHEK (-6670.82%) is worse than 99.47% of its industry peers.
Industry RankSector Rank
ROA -6670.82%
ROE N/A
ROIC N/A
ROA(3y)-2261.03%
ROA(5y)-1376.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CHEK Yearly ROA, ROE, ROICCHEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CHEK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CHEK Yearly Profit, Operating, Gross MarginsCHEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

CHEK has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHEK has more shares outstanding
CHEK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHEK Yearly Shares OutstandingCHEK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
CHEK Yearly Total Debt VS Total AssetsCHEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

CHEK has an Altman-Z score of -715.53. This is a bad value and indicates that CHEK is not financially healthy and even has some risk of bankruptcy.
CHEK has a worse Altman-Z score (-715.53) than 97.37% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -715.53
ROIC/WACCN/A
WACCN/A
CHEK Yearly LT Debt VS Equity VS FCFCHEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

CHEK has a Current Ratio of 0.15. This is a bad value and indicates that CHEK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CHEK (0.15) is worse than 96.32% of its industry peers.
CHEK has a Quick Ratio of 0.15. This is a bad value and indicates that CHEK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.15, CHEK is doing worse than 95.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.15
Quick Ratio 0.15
CHEK Yearly Current Assets VS Current LiabilitesCHEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

0

3. Growth

3.1 Past

CHEK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -43.15%.
EPS 1Y (TTM)-43.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-587.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y7.34%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHEK Yearly EPS VS EstimatesCHEK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CHEK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CHEK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CHEK Price Earnings VS Forward Price EarningsCHEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CHEK Per share dataCHEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -1 -2 -3 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CHEK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHECK CAP LTD

NASDAQ:CHEK (10/24/2025, 8:15:05 PM)

After market: 1.59 -0.03 (-1.85%)

1.62

+0.08 (+5.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)N/A N/A
Inst Owners2.13%
Inst Owner Change0%
Ins Owners6.15%
Ins Owner ChangeN/A
Market Cap11.37M
Revenue(TTM)N/A
Net Income(TTM)-25149000
Analysts43.33
Price TargetN/A
Short Float %8.52%
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.3
EYN/A
EPS(NY)-2.45
Fwd EYN/A
FCF(TTM)-1.14
FCFYN/A
OCF(TTM)-1.14
OCFYN/A
SpS0
BVpS-0.21
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6670.82%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2261.03%
ROA(5y)-1376.9%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.15
Quick Ratio 0.15
Altman-Z -715.53
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-587.29%
EPS Next Y7.34%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y47.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.79%
OCF growth 3YN/A
OCF growth 5YN/A

CHECK CAP LTD / CHEK FAQ

Can you provide the ChartMill fundamental rating for CHECK CAP LTD?

ChartMill assigns a fundamental rating of 0 / 10 to CHEK.


Can you provide the valuation status for CHECK CAP LTD?

ChartMill assigns a valuation rating of 0 / 10 to CHECK CAP LTD (CHEK). This can be considered as Overvalued.


How profitable is CHECK CAP LTD (CHEK) stock?

CHECK CAP LTD (CHEK) has a profitability rating of 0 / 10.


What is the expected EPS growth for CHECK CAP LTD (CHEK) stock?

The Earnings per Share (EPS) of CHECK CAP LTD (CHEK) is expected to grow by 7.34% in the next year.